Envy Medical, Inc., the makers of Lumixyl, the new breakthrough topical system for skin brightening, has released a new video short that highlights the science behind the Lumixyl System. The video can be found at the following link: http://youtu.be/AJVJ0iz5FCs;
Lumixyl is considered by many to be the first real alternative to hydroquinone and other harsh “skin bleaching” products. Lumixyl is not a skin bleacher, rather it is based on peptide technologies developed by a team of Stanford University researchers, that helps the skin reduce the overproduction of melanin, the most common cause of hyperpigmentation and patchy discoloration in skin.
The video features a short introduction to Lumixyl, what it does and how it works by Felipe Jimenez, Ph.D., the Chief Scientific Officer for Envy Medical, and a protein biochemist by training. In the presentation, Dr. Jimenez explains that hyperpigmentation is a “multi-factorial skin problem” and suggests that you need multiple approaches to really get rid of it.
As Dr. Jimenez explains, the Lumixyl Topical Brightening System was designed to comprehensively address all of the causes of uneven skin tone and to do it safely and effectively within a skincare system that can be used as your daily skincare regimen for healthy looking and healthy acting skin. The system includes an antioxidant rich cleanser (Active-Prep), a rapid exfoliating lotion (GlycoPeel 20), and a broad spectrum physical sunscreen (MoistureLock SPF 30) in addition to the patented decapeptide-12 Topical Brightening Creme.
The Lumixyl System is sold through dermatologists, cosmetic surgeons and medical-spa physician offices. Patients can expect to see significant results within 6 to 8 weeks, but because the system contains no hydroquinone or prescription retinoids, it can be used for as long or as often as is desired to boost the skin’s radiance and maintain optimal skin tone and texture.
The video is part of a series in skin health education that the company is planning to release. It will be featured in doctors’ offices around the country as part of their resources for educating their patients on the benefits of this exciting new skin brightening system.
More information on the Lumixyl Topical Brightening System and the exciting new Lumixyl SilkPeel procedure can be found HERE at the ENVY Medical website. To find a Lumixyl physician near you, click HERE.
About Lumixyl. Lumixyl is manufactured and marketed by Envy Medical, Inc. Envy Medical develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. The Company’s lead products include SilkPeel®, a breakthrough device combining exfoliation with Dermalinfusion™ for deeper tissue delivery of active ingredients and better patient outcomes. Envy is also the exclusive licensor of skin brightening peptides including Lumixyl, developed at Stanford University. The Lumixyl peptide is now also available in a topical solution for SilkPeel procedures, addressing hyperpigmentation and photo-damage. More information can be found at www.envymedical.com or by calling (888) 848-3633.
For media inquiries or to secure expert testimonial please contact Melissa Kelz, Principal, Melissa Kelz PR at firstname.lastname@example.org (312) 543-8300